Combinatorial pathway disruption is a powerful approach to delineate metabolic impacts of endocrine disruptors

Archive ouverte

Bernal, Kévin | Touma, Charbel | Erradhouani, Chedi | Boronat-Belda, Talía | Gaillard, Lucas | Al Kassir, Sara | Le Mentec, Hélène | Martin-Chouly, Corinne | Podechard, Normand | Lagadic-Gossmann, Dominique | Langouët, Sophie | Brion, François | Knoll-Gellida, Anja | Babin, Patrick | Sovadinová, Iva | Babica, Pavel | Andreau, Karine | Barouki, Robert | Vondráček, Jan | Alonso-Magdalena, Paloma | Blanc, Étienne | Kim, Min Ji | Coumoul, Xavier

Edité par CCSD ; Wiley -

International audience. The prevalence of metabolic diseases, such as obesity, diabetes, metabolic syndrome and chronic liver diseases among others, has been rising for several years. Epidemiology and mechanistic ( in vivo , in vitro and in silico ) toxicology have recently provided compelling evidence implicating the chemical environment in the pathogenesis of these diseases. In this review, we will describe the biological processes that contribute to the development of metabolic diseases targeted by metabolic disruptors, and will propose an integrated pathophysiological vision of their effects on several organs. With regard to these pathomechanisms, we will discuss the needs, and the stakes of evolving the testing and assessment of endocrine disruptors to improve the prevention and management of metabolic diseases that have become a global epidemic since the end of last century.

Suggestions

Du même auteur

Obesity III: Obesogen assays: Limitations, strengths, and new directions

Archive ouverte | Kassotis, Christopher D | CCSD

International audience. There is increasing evidence of a role for environmental contaminants in disrupting metabolic health in both humans and animals. Despite a growing need for well-understood models for evaluati...

Obesity II: Establishing causal links between chemical exposures and obesity

Archive ouverte | Heindel, Jerrold J | CCSD

International audience. Obesity is a multifactorial disease with both genetic and environmental components. The prevailing view is that obesity results from an imbalance between energy intake and expenditure caused ...

Assessment of endocrine disruptor impacts on lipid metabolism in a fatty acid-supplemented HepaRG human hepatic cell line

Archive ouverte | Bernal, Kévin | CCSD

International audience. The incidence of metabolic dysfunction-associated steatotic liver disease (MASLD) is increasing worldwide. This disease encompasses several stages, from steatosis to steatohepatitis and, even...

Chargement des enrichissements...